Development of Blood Glucose Control for Extremely Premature Infants (2011)

View/ Open
Type of Content
Journal ArticlePublisher
University of Canterbury. Mechanical EngineeringISSN
0169-2607Collections
Abstract
Extremely premature neonates often experience hyperglycaemia, which has been linked to increased mortality and worsened outcomes. Insulin therapy can assist in controlling blood glucose levels and promoting needed growth. This study presents the development of a model-based stochastic targeted controller designed to adapt insulin infusion rates to match the unique and changing metabolic state and control parameters of the neonate. Long-term usage of targeted BG control requires successfully forecasting variations in neonatal metabolic state, accounting for differences in clinical practices between units, and demonstrating robustness to errors that can occur in everyday clinical usage. Simulation studies were used to evaluate controller ability to target several common BG ranges and evaluate controller sensitivity to missed BG measurements and delays in control interventions on a virtual patient cohort of 25 infants developed from retrospective data. Initial clinical pilot trials indicated model performance matched expected performance from simulations. Stochastic targeted glucose control developed using validated patient-specific virtual trials can yield effective protocols for this cohort. Long-term trials show fundamental success, however clinical interface design appears as a critical factor to ensuring good compliance and thus good control.
Citation
LeCompte, A.J., Chase, J.G., Lynn, A., Hann, C.E., Shaw, G.M., Lin, J. (2011) Development of Blood Glucose Control for Extremely Premature Infants. Computer Methods and Programs in Biomedicine, 102(2), pp. 181-191.This citation is automatically generated and may be unreliable. Use as a guide only.
Keywords
Glucose; simulation; insulin; control; real-time; neonate; user interface.ANZSRC Fields of Research
32 - Biomedical and clinical sciences::3202 - Clinical sciences::320212 - Intensive care32 - Biomedical and clinical sciences::3202 - Clinical sciences::320208 - Endocrinology
32 - Biomedical and clinical sciences::3201 - Cardiovascular medicine and haematology::320102 - Haematology
40 - Engineering::4003 - Biomedical engineering::400303 - Biomechanical engineering
Related items
Showing items related by title, author, creator and subject.
-
Intensive Control Insulin-Nutrition-Glucose Model Validated in Critically Ill Patients
Lin, J.; Razak, N.N.; Pretty, C.G.; LeCompte, A.J.; Docherty, P.D.; Parente, J.D.; Shaw, Geoff; Hann, C.E.; Chase, Geoff (University of Canterbury. Electrical and Computer EngineeringUniversity of Canterbury. Mathematics and StatisticsUniversity of Canterbury. Mechanical Engineering, 2010)A comprehensive, more physiologically relevant Intensive Control Insulin-Nutrition- Glucose (ICING) Model is presented and validated using data from critically ill patients. Glucose utilisation and its endogenous production ... -
Modeling the glucose regulatory system in extreme preterm infants
Le Compte, A.J.; Chase, Geoff; Russell, G.; Lynn, A.; Hann, C.E.; Shaw, Geoff; Wong, X-W.; Blakemore, A.; Lin, J. (University of Canterbury. Electrical and Computer EngineeringUniversity of Canterbury. Mechanical Engineering, 2011)BACKGROUND: Premature infants represent a significant proportion of the neonatal intensive care population. Blood glucose homeostasis in this group is often disturbed by immaturity of endogenous regulatory systems and the ... -
Tight Glycemic Control in Critical Care - The leading role of insulin sensitivity and patient variability – A review and model-based analysis
Chase, Geoff; Le Compte, A.J.; Suhaimi, F.; Shaw, Geoff; Lynn, A.; Lin, J.; Pretty, Christopher; Razak, N.N.; Parente, J.D.; Hann, C.E.; Preiser, J-C.; Desaive, T. (University of Canterbury. Electrical and Computer EngineeringUniversity of Canterbury. Mathematics and StatisticsUniversity of Canterbury. Mechanical Engineering, 2011)Tight glycemic control (TGC) has emerged as a major research focus in critical care due to its potential to simultaneously reduce both mortality and costs. However, repeating initial successful TGC trials that reduced ...